CRO.MOSCOW
Good work for the best health
Clinical trials and information for you
CRO.Moscow: our medicine and clinical trials
The plasmide "Neovasculgene" is the first in group medicine for revascularisation for therapy of limb ischemia.

We initiated the III and IV phases of clinical trials and we will glad to enjoy you in our study as a co-laborator or investigatar.


Registration

We'll glad to see you in our trials
By clicking the button, you agree to the terms of personal data